53 research outputs found
Diet and Exercise in the Treatment of Fatty Liver
In recent years, we came to realize that obesity, broadly defined as increased body mass index or increased total body fat, is not necessarily associated with metabolic dysfunction and greater risk for cardiometabolic disease. In fact, there are several obese persons who are "metabolically healthy," as there are nonobese persons who are "metabolically abnormal." Although the reason(s) underlying this phenomenon are still not entirely clear, a number of studies conducted over the past several years indicate that the anatomical location of excess fat is more important than total body adiposity in determining metabolic outcomes. Ectopic fat accumulation, particularly in the liver, is frequently observed in obese persons and is strongly associated with metabolic dysfunction, including multiorgan insulin resistance and dyslipidemia. Intrahepatic fat, possibly more than visceral or intramyocellular fat, may thus be a prominent factor modifying the metabolic risk associated with increasing whole-body adiposity. However, cause-and-effect relationships have not yet been established, and it is also possible that intrahepatic triglyceride content is not a determinant but merely a marker of metabolic health. Understanding the regulation of fat accumulation in the liver will thus have important implications in both research and clinical practice. Little is known regarding the specific effects of lifestyle factors such as diet and exercise in regulating the accumulation of fat in the liver and its depletion thereof. In this special issue, we have invited a few papers in an attempt to partly fill this gap in our knowledge. In the first paper of this issue, "Putative factors that may modulate the effect of exercise on liver fat: insights from animal studies," several studies in animals are reviewed in order to highlight putative factors that may modulate the effect of exercise on liver fat. This includes the fat content of the diet (exercise appears to be more effective under high-fat feeding), the role of concurrent exercise-induced loss of body weight or visceral fat, sex (males versus females), prandial status (fasted versus fed), and the duration of training, as well as the time elapsed from the last bout of exercise. The potential importance of these factors in modifying the exercise-induced changes in liver fat has not yet been formally tested in man, thereby providing a wide array of opportunities for future research. The second paper of this issue, "Nafld, estrogens, and physical exercise: the animal model," focuses on the effects of exercise on liver fat in relation to estrogen availability. Estrogen deficiency, such as that occurring naturally after menopause in women, is strongly associated with fatty liver in animals. Exercise training exerts an estrogenic-like effect on the expression of genes involved in hepatic lipid metabolism and is a powerful means for preventing liver fat accumulation in estrogen-deficient animals. The third paper of this special issue, "Dietary conjugated linoleic acid and hepatic steatosis: species specific effects on liver and adipose lipid metabolism and gene expression," reviews the effects of dietary conjugated linoleic acid on liver fat content and hepatic and adipose tissue fatty acid metabolism in animals. Conjugated linoleic acids, particularly the trans-10, cis-12, lead to hepatic steatosis owing to increased de novo lipogenesis and increased hepatic fatty acid uptake, at rates far exceeding the rates of disposal of intrahepatic fatty acids towards oxidation, esterification, and triglyceride export. The fourth paper of this issue, "Effects of exercise training on molecular markers of lipogenesis and lipid partitioning in fructose-induced liver fat accumulation," examines the effects of exercise training on liver fat in starved and subsequently fructose-refed animals. Fructose, a simple sugar, is a potent dietary trigger for liver fat accretion. Exercise training in this model is not able to reverse the fructose-induced changes in lipogenic enzymes and does not reduce intrahepatic fat content. Thus, contrary to the large body of evidence demonstrating that exercise is effective in alleviating hepatic steatosis induced by high-fat feeding, exercise is not able to reverse the changes induced by fructose feeding. The final paper of this special issue, "Exercise and omega-3 polyunsaturated fatty acid supplementation for the treatment of hepatic steatosis in hyperphagic OLETF rats," evaluates the effects of exercise on a hyperphagic model of obesity, with or without concurrent omega-3 polyunsaturated fatty acid supplementation. Exercise training in this animal model alleviates hepatic steatosis even under low-fat feeding conditions, predominantly by increasing hepatic fatty acid oxidation, whereas supplementation with omega-3 fatty acids slightly increases liver-fat content and attenuates the liver-fat-depleting effect of exercise. It is noteworthy that omega-3 fatty acid supplementation in this study accounted for only 3% of total dietary energy, whereas in several previous studies showing that omega-3 fatty acids reduce liver fat the supplement was administered at much greater doses. Research presented and reviewed in this special issue not only highlights the independent effects of exercise and diet on liver fat accumulation but also, more importantly, raises the intriguing possibility of interactive effects between exercise and diet on the mechanisms regulating liver fat accretion and depletion. It seems that several dietary factors are able to either augment or attenuate the intrahepatic triglyceride-depleting effect of exercise
A standardized scoring method for the copy of cube test, developed to be suitable for use in psychiatric populations
BACKGROUND: Although the 'copy of cube test', a version of which is included in the Short Test of Mental Status (STMS), has existed for years, little has been done to standardize it in detail. The aim of the current study was to develop a novel and detailed standardized method of administration and scoring this test. METHODS: The study sample included 93 healthy control subjects (53 women and 40 men) aged 35.87 ± 12.62 and 127 patients suffering from schizophrenia (54 women and 73 men) aged 34.07 ± 9.83 years. The psychometric assessment included the Positive and Negative Symptoms Scale (PANSS) the Young Mania Rating Scale (YMRS), and the Montgomery-Åsberg Depression Rating Scale (MADRS). RESULTS: A scoring method was developed based on the frequencies of responses of healthy controls. Cronbach's α was equal to 0.75 and inter-rater reliability was 0.90. Three indices and five subscales of the Standardized Copy of the Cube Test (SCCT) were eventually developed. They included the Deficit Index (DcI), which includes the Missing Elements (ME) Mirror Image (M) subscales, the Deformation Index (DfI) which includes the Deformation (D) and the Rotation (R) subscales and the Closing-In Index (CiI). DISCUSSION: The SCCT seems to be a reliable, valid and sensitive to change instrument for the testing of psychiatric patients. The great advantage of this instrument is the fact that it only requires paper and a pencil, and is this easily administered and brief. Further research is necessary to test its usefulness as a neuropsychological test
The standardised copy of pentagons test
<p>Abstract</p> <p>Background</p> <p>The 'double-diamond copy' task is a simple paper and pencil test part of the Bender-Gestalt Test and the Mini Mental State Examination (MMSE). Although it is a widely used test, its method of scoring is crude and its psychometric properties are not adequately known. The aim of the present study was to develop a sensitive and reliable method of administration and scoring.</p> <p>Methods</p> <p>The study sample included 93 normal control subjects (53 women and 40 men) aged 35.87 ± 12.62 and 127 patients suffering from schizophrenia (54 women and 73 men) aged 34.07 ± 9.83.</p> <p>Results</p> <p>The scoring method was based on the frequencies of responses of healthy controls and proved to be relatively reliable with Cronbach's α equal to 0.61, test-retest correlation coefficient equal to 0.41 and inter-rater reliability equal to 0.52. The factor analysis produced two indices and six subscales of the Standardised Copy of Pentagons Test (SCPT). The total score as well as most of the individual items and subscales distinguished between controls and patients. The discriminant function correctly classified 63.44% of controls and 75.59% of patients.</p> <p>Discussion</p> <p>The SCPT seems to be a satisfactory, reliable and valid instrument, which is easy to administer, suitable for use in non-organic psychiatric patients and demands minimal time. Further research is necessary to test its psychometric properties and its usefulness and applications as a neuropsychological test.</p
Cholesterol Synthesis Is Associated with Hepatic Lipid Content and Dependent on Fructose/Glucose Intake in Healthy Humans
Visceral obesity and fatty liver have been related to high synthesis and low absorption of cholesterol. This study aimed to investigate the associations of cholesterol metabolism with liver and visceral fat content in healthy humans. Another objective was to explore the effects of very-high-fructose and very-high-glucose diets on cholesterol homeostasis. We report on a cohort of 20 people (12 males, 8 females; age 30.5 ± 2.0 years; body mass index 25.9 ± 0.5 kg/m2) who completed a four-week dietary intervention study. Between the baseline and the followup examination the study participants in addition to a balanced weight-maintaining diet received 150 g of either fructose or glucose per day. Visceral and liver fat were measured with magnetic resonance (MR) imaging and 1H-MR spectroscopy, respectively. Cholesterol absorption and synthesis were estimated from the serum noncholesterol sterol concentrations. Performing cross-sectional analyses the lanosterol and desmosterol to cholesterol ratios were positively correlated with visceral and liver fat content (all P < .03). The lathosterol to cholesterol ratio decreased in response to high-fructose diet (P = .006) but not in response to high-glucose diet. To conclude, visceral and liver fat content are associated with cholesterol synthesis in healthy humans. Furthermore, cholesterol synthesis appears to be dependent on fructose/glucose intake
Polymorphisms within Novel Risk Loci for Type 2 Diabetes Determine β-Cell Function
BACKGROUND: Type 2 diabetes arises when insulin resistance-induced compensatory insulin secretion exhausts. Insulin resistance and/or beta-cell dysfunction result from the interaction of environmental factors (high-caloric diet and reduced physical activity) with a predisposing polygenic background. Very recently, genetic variations within four novel genetic loci (SLC30A8, HHEX, EXT2, and LOC387761) were reported to be more frequent in subjects with type 2 diabetes than in healthy controls. However, associations of these variations with insulin resistance and/or beta-cell dysfunction were not assessed. METHODOLOGY/PRINCIPAL FINDINGS: By genotyping of 921 metabolically characterized German subjects for the reported candidate single nucleotide polymorphisms (SNPs), we show that the major alleles of the SLC30A8 SNP rs13266634 and the HHEX SNP rs7923837 associate with reduced insulin secretion stimulated by orally or intravenously administered glucose, but not with insulin resistance. In contrast, the other reported type 2 diabetes candidate SNPs within the EXT2 and LOC387761 loci did not associate with insulin resistance or beta-cell dysfunction, respectively. CONCLUSIONS/SIGNIFICANCE: The HHEX and SLC30A8 genes encode for proteins that were shown to be required for organogenesis of the ventral pancreas and for insulin maturation/storage, respectively. Therefore, the major alleles of type 2 diabetes candidate SNPs within these genetic loci represent crucial alleles for beta-cell dysfunction and, thus, might confer increased susceptibility of beta-cells towards adverse environmental factors
Erythrocyte and Liver Porphobilinogen Deaminase in Cirrhosis and Clinical or Experimental Cholestasis
Association of Type 2 Diabetes Candidate Polymorphisms in KCNQ1 With Incretin and Insulin Secretion
Evaluation of Fasting State-/Oral Glucose Tolerance Test-Derived Measures of Insulin Release for the Detection of Genetically Impaired β-Cell Function
Novel Meta-Analysis-Derived Type 2 Diabetes Risk Loci Do Not Determine Prediabetic Phenotypes
BACKGROUND: Genome-wide association (GWA) studies identified a series of novel type 2 diabetes risk loci. Most of them were subsequently demonstrated to affect insulin secretion of pancreatic beta-cells. Very recently, a meta-analysis of GWA data revealed nine additional risk loci with still undefined roles in the pathogenesis of type 2 diabetes. Using our thoroughly phenotyped cohort of subjects at an increased risk for type 2 diabetes, we assessed the association of the nine latest genetic variants with the predominant prediabetes traits, i.e., obesity, impaired insulin secretion, and insulin resistance. METHODOLOGY/PRINCIPAL FINDINGS: One thousand five hundred and seventy-eight metabolically characterized non-diabetic German subjects were genotyped for the reported candidate single nucleotide polymorphisms (SNPs) JAZF1 rs864745, CDC123/CAMK1D rs12779790, TSPAN8/LGR5 rs7961581, THADA rs7578597, ADAMTS9 rs4607103, NOTCH2 rs10923931, DCD rs1153188, VEGFA rs9472138, and BCL11A rs10490072. Insulin sensitivity was derived from fasting glucose and insulin concentrations, oral glucose tolerance test (OGTT), and hyperinsulinemic-euglycemic clamp. Insulin secretion was estimated from OGTT data. After appropriate adjustment for confounding variables and Bonferroni correction for multiple comparisons (corrected alpha-level: p = 0.0014), none of the SNPs was reliably associated with adiposity, insulin sensitivity, or insulin secretion (all p > or = 0.0117, dominant inheritance model). The risk alleles of ADAMTS9 SNP rs4607103 and VEGFA SNP rs9472138 tended to associate with more than one measure of insulin sensitivity and insulin secretion, respectively, but did not reach formal statistical significance. The study was sufficiently powered (1-beta = 0.8) to detect effect sizes of 0.19 < or = d < or = 0.25 (alpha = 0.0014) and 0.13 < or = d < or = 0.16 (alpha = 0.05). CONCLUSIONS/SIGNIFICANCE: In contrast to the first series of GWA-derived type 2 diabetes candidate SNPs, we could not detect reliable associations of the novel risk loci with prediabetic phenotypes. Possible weak effects of ADAMTS9 SNP rs4607103 and VEGFA SNP rs9472138 on insulin sensitivity and insulin secretion, respectively, await further confirmation by larger studies
- …